Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • A Study of Watchful Waiting After Chemotherapy and Radiotherapy Compared to Surgery for Patients with Early Rectal Cancer Using Capecitabine

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden
  • Study on Organ Preservation in Advanced Rectal Cancer Patients Using Bleomycin and Electrochemotherapy After Initial Treatment

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Study on Capecitabine and Oxaliplatin for High-Risk Rectal Cancer Patients to Reduce Metastases

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland
  • Study of Durvalumab with Drug Combination for Patients with Locally Advanced Rectal Cancer

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Spain
  • Study on Valproic Acid with Bevacizumab and Oxaliplatin/Fluoropyrimidine for Patients with RAS-Mutated Metastatic Colorectal Cancer

    Not recruiting

    1 1 1
    Italy
  • Study on Atezolizumab for Patients with High-Risk Stage II or Stage III Colorectal Cancer Not Eligible for Oxaliplatin Chemotherapy

    Not recruiting

    1 1 1
    Investigated drugs:
    Germany
  • Study Comparing Short Course Radiotherapy and Chemoradiotherapy with Fluorouracil, Calcium Folinate, and Capecitabine for Intermediate and High-Risk Rectal Cancer Patients

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Germany
  • Study on Capecitabine and Oxaliplatin for Patients with High Risk Rectal Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Study on Induction Chemotherapy with Irinotecan, Folinic Acid, Fluorouracil, and Oxaliplatin for Patients with High-Risk Locally Advanced Rectal Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    The Netherlands
  • Study on Aspirin’s Effect on Recurrence and Survival in Patients with Non-Metastatic Breast, Colon, Rectal, Stomach, Esophageal, and Prostate Cancer

    Not recruiting

    1 1 1
    Investigated drugs:
    Ireland